Adagio Medical Holdings, Inc. (ADGM) — Institutional Holders & Catalysts | BiotechEdge

Catalysts Convergence Squeeze Signals Cash Runway Insiders Research

Home›Companies›Adagio Medical Holdings, Inc. (ADGM)

Adagio Medical Holdings, Inc.

ADGM

Held by 2 specialist biotech funds

2 funds opened new positions. Short interest: 0.1% of float.

Score Holdings Short Interest Catalysts Insiders Research

Signal Score

4.0/10

2 funds opened new positions

BiotechEdge

Catalysts Conferences Companies Convergence Fund Insiders Signals Squeeze Cash Runway Research Weekly Briefs 13F Changes Glossary PricingSign In Start 14-Day Free Trial

Data sourced from SEC EDGAR and ClinicalTrials.gov. Not investment advice.

Feedback

●●

No recent insider activity●●

No upcoming catalysts●●

Held by 2 specialist funds●●

See how each signal contributes— fund overlap, insider activity, catalyst timing, short interest (free trial)

Fund Holdings

Perceptive AdvisorsHeld 4Q

RTW Investments

Position history (shares)

Perceptive Advisors

RTW Investments

4 quarters

Position Trend

Aug 6, 2025

$7.9M

1 fund

Aug 14, 2025

$13.1M

2 funds

Nov 14, 2025

$19.6M

2 funds

Feb 17, 2026

$10.3M

1 fund

+5978% total institutional value over 5 quarters

Short Interest

Shorts covering

Short Shares

15K

Change

-79.5%

Days to Cover

0.4

% of Float

0.1%

Settlement

Mar 13, 2026

Short interest over 2 periods

Catalysts

No catalysts tracked.

Activist Filings

SC 13G/APerceptive Advisors57.5%Feb 17, 2026

SC 13G/ARA Capital Management7.2%Aug 26, 2025

SC 13G/ARA Capital Management0.0%Aug 14, 2025

SC 13G/ARA Capital Management7.2%May 15, 2025

SC 13G/ARA Capital Management9.9%Feb 14, 2025

SC 13G/APerceptive Advisors73.6%Feb 14, 2025

SC 13GRA Capital Management10.0%Aug 12, 2024

Position Details

Perceptive AdvisorsFeb 17, 2026

Start free trialfor share counts, dollar values & AI analysis

7 more position changes — start your free trial to see dollar values and AI analysis for all of them.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 14-Day Free Trial — $29/mo

Insider Signals

No insider purchases or sales detected in the past 90 days.

Also Held by These Funds

AAVXF2 funds AQST2 funds CELC2 funds KOD2 funds CRVS2 funds KYMR2 funds BBNX2 funds LENZ2 funds

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Related Research

Verdad's Biotech White Paper, Part 1: Why Specialist Fund Holdings Predict Returns

6 min read

Verdad's Biotech White Paper, Part 2: Why Traditional Quant Factors Fail — and What Works Instead

6 min read

Fund Convergence: The Highest-Conviction Signal in Biotech Investing

5 min read

Track specialist biotech funds, insider signals, and AI analysis

Start 14-Day Free Trial

Get free weekly alerts on fund moves and catalysts:

Terms

Privacy

Disclaimer